189 related articles for article (PubMed ID: 36816764)
1. Subsequent participation in organized FIT based screening following screen-derived colonoscopy
Bülow Therkildsen S; Larsen PT; Njor S
Prev Med Rep; 2023 Apr; 32():102125. PubMed ID: 36816764
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
Larsen PT; Jørgensen SF; Njor SH
BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
4. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
[No Abstract] [Full Text] [Related]
5. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
[TBL] [Abstract][Full Text] [Related]
7. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
Elife; 2023 Jan; 12():. PubMed ID: 36695411
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
9. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
10. Mental disorders, participation, and trajectories in the Danish colorectal cancer programme: a population-based cohort study.
Thomsen MK; Jørgensen MD; Pedersen L; Erichsen R; Sørensen HT; Mikkelsen EM
Lancet Psychiatry; 2023 Jul; 10(7):518-527. PubMed ID: 37353263
[TBL] [Abstract][Full Text] [Related]
11. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
[TBL] [Abstract][Full Text] [Related]
12. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
13. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E
Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study.
Njor SH; Larsen MB; Søborg B; Andersen B
J Med Screen; 2022 Dec; 29(4):241-248. PubMed ID: 35635233
[TBL] [Abstract][Full Text] [Related]
15. The relative effectiveness of fecal immunochemical test-based colorectal cancer screening to detect adenomas and cancer in different demographic and socioeconomic groups. A nationwide cohort study.
Larsen MB; Søborg B; Njor SH; Jensen TM; Ingeholm P; Andersen B
Eur J Cancer Prev; 2022 Nov; 31(6):489-496. PubMed ID: 35485399
[TBL] [Abstract][Full Text] [Related]
16. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
[TBL] [Abstract][Full Text] [Related]
17. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
[TBL] [Abstract][Full Text] [Related]
18. Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis.
Chen H; Wang L; Lu M; Zhu C; Zhu Y; Ma W; Chen X; Du L; Chen W
Chin J Cancer Res; 2021 Aug; 33(4):512-521. PubMed ID: 34584376
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
